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http://dx.doi.org/10.1016/j.kjms.201Abstract This study aimed to investigate the role of the Toll-like receptor 4 (TLR4) pathway
in normal human gastric epithelial (GES-1) cells under hypoxia/reoxygenation (H/R) in vitro,
and the effect of propofol on injured GES-1 cells as well as its possible mechanism. Before
H/R induction, GES-1 cells were preconditioned with fat emulsion, propofol, or epigallocate-
chin gallate. Then cell viability, cell apoptosis, and related molecules in the cells were
analyzed under experimental conditions. We found that propofol 50 mmol/L markedly inhibited
the H/R injury under hypoxia 1.5 h/reoxygenation 2 hours by promoting GES-1 cell viability and
decreasing cell apoptosis. The TLR4 signal may be involved in the protective effect of propofol
against H/R injury. The malondialdehyde contents and superoxide dismutase activities were
recovered under propofol preconditioning. In summary, propofol preconditioning may exert
a protective effect on H/R injury in GES-1 cells and the mechanism may be via inhibition of
the activated TLR4 signal under H/R conditions.
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.rovince Key Laboratory of
ge, 84 West Huaihai Road,
com (Y.-M. Zhang).
hsiung Medical University. Publish
2.10.006Introduction
Lots of stressors, such as trauma [1] and surgery, can lead
to tissue ischemia. So-called gastric mucosa ischemice-
reperfusion injury (I/RI) is that it was injured when blood
flow was restored [2]. However, there are few desirable
treatments for gastric I/RI in the clinic. Recently, ischemiced by Elsevier Taiwan LLC. All rights reserved.
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to be significant methods in endogenous protection, which
can significantly reduce I/RI [3].
Most recent studies on TLRs have focused on immune
cells known to be involved in innate immunity, such as
dendritic cells (DCs), monocytes, granulocytes and their
inflammatory reactions [4]. Toll-like receptor 4 (TLR4), one
of the TLR family members, has been shown to be expressed
in many tissues, including gastric endothelial cells [4] and
cardiomyocytes [5]. Studies have suggested that the TLR4
signal can be mediated through myeloid differentiation
protein 88 (MyD88)-dependent and MyD88-independent
pathways [6]. Classically, the MyD88-dependent pathway
derives from the Toll/interleukin-1 receptor domain. The
activated Toll/interleukin-1 receptor facilitates nuclear
factor-kappa B (NF-kB) translocation into the nucleus and
controls the phosphorylation of inhibitory protein of NF-kB
(IkB-a) [7]. The TLR4 signal was restricted to the MyD88-
dependent pathway in endothelial cells lacking of some
adaptors, such as the Toll/interleukin-1receptor domain-
containing adaptor protein inducing interferon-b [4].
Previous studies have suggested that TLR4 plays a crit-
ical role in multiple organs’ I/RI, such as the lungs [8], heart
[9] and hepar [10]. Meanwhile, however, whether or not the
TLR4 signal is involved in human gastric epithelial cell
injury induced by hypoxia/reoxygenation (H/R) remains
unclear. In this study, Western blotting was used to detect
TLR4 as well as downstream molecule expression. Epi-
gallocatechin gallate (EGCG), an inhibitor of TLR4 [11], was
used to further define the role of TLR4 in human gastric
epithelial (GES-1) cell injury induced by H/R by detecting
cell viability.
It is well known that oxidative stress plays a critical role
in I/RI. Malondialdehyde (MDA) is an end product of 1ipid
peroxidation, whose level is a marker of the severity of
cells being attacked by oxygen free radical (OFR). Super-
oxide dismutase (SOD) is a major endogenous anti-oxidant
in cells, whose activity reflects the ability of OFR scav-
enging. Therefore, the amount of MDA and level SOD
activities in GES-1 cells under H/R conditions were
measured.
Propofol is a widely used anesthetic agent for the
induction and maintenance of anesthesia, not only during
surgical operations, but also for sedation in patients who
are seriously ill. In recent years, propofol has increasingly
been used in painless gastroscopy. It has been reported that
propofol is an immunomodulatory drug [12]. Furthermore,
propofol has been indicated to have protective effects
against I/RI in the heart [13,14] and brain [15,16]. Whether
propofol has a protective effect on H/R-induced injury in
gastric epithelial cells in vitro and its possible mechanism
of action, however, are not clear. Thus, we measured cell
viability, cell apoptosis, apoptotic-related proteins (Bax/
Bcl-2) and proteins involved in TLR4 signaling to determine
the effect of propofol in H/R injury in GES-1 cells [17] and
elucidate the underlying mechanism. Studies have indi-
cated that propofol has antioxidant activity [18,19], so
colorimetry was used to detect the change in the amount of
MDA and level of SOD activities in injured GES-1 cells under
propofol preconditioning.In summary, the role of the TLR4 signal pathway in
gastric epithelial cell injury under H/R and the novel
pharmacological effect of propofol on the injured cells
were investigated in our study.Materials and methods
Reagents
The following reagents were used:
 phenol red-free Dulbecco’s modified Eagle’s medium
(DMEM) (GIBCO Co., State of California, USA);
 propofol (Astra Zeneca, Basiglio, Italy);
 fat emulsion (Huarui Pharmaceuticals Co. Ltd, Wuxi,
China);
 EGCG (Shanghai Yuanye Biotechnology Co. Ltd., China);
 RPMI-1640 and Hoechst 33258 (Sigma-Aldrich Co., State
of Missouri, USA);
 fetal bovine serum (FBS) (Zhejiang Tianhang Biological
Manufacture Co. Ltd., China);
 3-(4, 5-dimethylthazol- 2-yl)-2, 5-diphenyl tetrazolium
bromide (MTT) (Amresco, Solon, OH, USA).
The MDA and SOD detection kits were produced by the
Nanjing Jiancheng Bioengineering Institute, China, and the
annexin fluorescein isothiocyanate (V-FITC) cell apoptosis
detection kit was produced by Beijing Baosai Biotechnology
Co. Ltd., China.
The following products from Santa Cruz Biotechnology
(USA) were also used:
 goat polyclonal anti-TLR4 (sc-16240);
 rabbit polyclonal anti-MyD88 (sc-11356);
 mouse monoclonal anti-NF-kB P65 (sc-8008);
 rabbit polyclonal anti-IkB-a (sc-371);
 mouse monoclonal anti-p-IkB-a (sc-8404);
 rabbit polyclonal anti-Bax (sc-526); and
 rabbit polyclonal anti-Bcl-2 (sc-492).
The following products from ZSGB-BIO (China) were also
used:
 mouse anti-beta actin monoclonal antibody (TA-09);
 alkaline phosphatase goat anti-rabbit IgG (ZB-2308);
 alkaline phosphatase horse anti-mouse IgG (ZB-2310);
and
 alkaline phosphatase rabbit anti-goat IgG (ZB-2311).
The cDNA was provided by Shanghai Bioengineering Co.
Ltd. (China).
Cell culture
The normal human GES-1 cell line was obtained from Bei-
jing Cancer Hospital. Cells were maintained in DMEM con-
taining 10% FBS and placed in a humid incubator with 95%
air and 5% CO2 at 37 C.
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The complete medium was replaced with DMEM containing
1% FBS 1 day before the experiment to synchronize the
cells. The cells were randomly divided into different groups
and treated as follows:
 cells in the normal group (N) were kept under normoxic
culture;
 in the hypoxia/reoxygenation (H/R) group, the DMEM
was replaced with RPMI-1640 medium before hypoxia
induction, cells were transferred into a humid atmo-
sphere equilibrated with 94% N2 þ 1% O2 þ 5% CO2 (for
hypoxia), then the medium was replaced with complete
medium to simulate reoxygenation in normoxic culture;
 in the propofol preconditioning (P) group, DMEM was
replaced with RPMI-1640 medium containing propofol,
and the other procedures were same as the H/R group;
 in the fat emulsion group (F), the DMEM was replaced
with RPMI-1640 medium containing fat emulsion, and
the other procedures were same as the H/R group;
 in the EGCG preconditioning group (E) and EGCG plus
propofol preconditioning group, DMEM was replaced
with RPMI-1640 medium containing EGCG (1 mmol/L)
and EGCG 1 mmol/L plus propofol 50 mmol/L respec-
tively. Other procedures were same as the H/R group.
Cell viability
GES-1 cells (1 104 cells/mL) were cultured in 96-well plates.
Following the experiment, the cells were treated with 25 mL
MTT (5 g/L) and incubated for 4 hours in darkness at 37 C.
After removing the medium, the MTT-formazan crystals were
dissolved in DMSO (200 mL/well) and maintained for 10
minutes. Cell viability was determined as a percentage using
the following relationship:(ODA570nm in experimental group/
ODA570nm in normal control group) 100%.
Hoechst 33258 staining assay
GES-1 cells (1  104 cells/mL) were incubated in six-well
plates. After the experiment, the supernatants were dis-
carded and the cells were fixed with paraform, and then
the cells were washed with PBS (3 minutes  2), followed
by staining with Hoechst 33258 (0.5 mL/well). The
proportion of apoptotic GES-1 cells was determined by
manually counting the number of pyknotic nuclei under
fluorescence microscopy.
Flow cytometric analysis
The experimental GES-1 cells (1  104 cells/mL) were
cultured in six-well plates. Following the experiments, the
cells were harvested and washed with cold PBS three or
four times, and the cells were resuspended in 200 mL
binding buffer. Then 10 mL of annexin V-FITC was added to
the cell suspensions and incubated at room temperature
for 15 minutes in darkness. Next, 300 mL binding buffer and
5 mL propidium iodide were added into the cell suspen-
sions, mixed gently and the samples were kept on ice. The
stained cells were analyzed using flow cytometry (BectonDickinson, USA) to determine the percentage of apoptotic
cells.
Western blotting analysis
GES-1 cells were plated in flasks and incubated for 24 hours.
After the experiment, the cells were washed with cold PBS
for twice before the mixture of radioimmunoprecipitation
assay (RIPA) lysis buffer and phenylmethyl sulfonylfluoride
(PMSF) (100:1, 200 mL) were added into the flasks and placed
on ice for 30 minutes to split the cells. The cell fragments
were harvested and centrifuged for supernatant collection
(total proteins). The nuclear pellets were dissolved in lysis
buffer (50 mL) again and recentrifuged for supernatant
collection (nuclear proteins). The protein concentrations
were determined by bicinchoninic acid (BCA) assay. Lysates
were boiled in sample buffer for 5 minutes and then the
proteins were subjected to sodium dodecyl sulfate poly-
acrylamide gel electrophoresis and transferred to nitrocel-
lulose (NC) membrane using a semi-dry electroblotting
system. After blocking the nonspecific antigen with blocking
buffer, the membranes were incubated with (1:200) primary
antibodies at 4 C overnight followed by incubation with
(1:500) corresponding alkaline phosphatase-conjugated
secondary antibodies at room temperature for 2 hours.
Protein expression was analyzed quantitatively by densi-
tometry with Photoshop (version 8.1).
Quantitative real-time polymerase chain reaction
GES-1 cells (5  104 cells/mL) were cultured in six-well
dishes. At the end of experiment, the total mRNA was
extracted from cells for real-time polymerase chain reac-
tion. The amount of b-actin transcript present was quan-
tified as an internal mRNA control. Quantitative values
were obtained from the threshold cycle value (annealing
temperature, 55 C). The primers used for b-actin were 50-T
GACGTGGACATCCGCAAAG-30 and 50-CTGGAAGGTGGACAGC
GAGG-30; and for TLR4 were 50-TTCCCAGAACTGCAGGTGC
T-30 and 50-GATGTCCAATGGGGAAGTTCTC T-30.
Measurement of MDA content and SOD activity
MDA was measured with thiobarbituric acid chroma-
tometry. After the experiment, the GES-1 cells were har-
vested and centrifuged for supernatant collection. The
supernatant concentrations were determined by the BCA
assay, and then the reagents involved were added and
mixed together. The suspension was placed in boiling water
for 40 minutes and was immediately cooled in ice-cold
water. After centrifugation at 4000 g for 10 minutes, the
intensity of absorbance of the upper phase was measured
by spectrophotometery (723N, Shanghai Precision & Scien-
tific Instrument Co. Ltd., China) at 532 nm. The MDA level
was expressed as nmol/mg protein.
SOD activity was assessed based on the inhibition of nitro
blue tetrazolium reduction by the xanthine oxidase system
as a superoxide generator. We obtained the SOD samples
using the same method as for measuring MDA. The reagents
involved were added to the supernatant and mixed
together. The suspension was placed in a water bath (37 C)
Figure 1. Effects of propofol preconditioning on GES-1 cell viability under H/R conditions. (A) normoxic culture for 15 hours;
H/R, hypoxia 3 hours/reoxygenation 12 hours; and propofol (1, 5, 10, 25, 50 and 100 mmol/L) preconditioning under hypoxia 3
hours/reoxygenation 12 hours. (B) Hypoxia (0.75, 1.5, 3, 6, 9 and 12 hours)/reoxygenation 12 hours, with propofol at 50 mmol/
L. (C) Hypoxia 1.5 hours/reoxygenation (1, 2, 4, 6, 8 and 12 hours) with propofol at 50 mmol/L. (D) Normoxic culture (N) for 3.5
hours; H/R, fat emulsion 50 mmol/L preconditioning (F) and propofol 50 mmol/L preconditioning (P) groups subjected to
hypoxia 1.5 hours/reoxygenation 2 hours. Means  standard deviation, n Z 6. *p < 0.05 vs. N group. #p < 0.05. ##p < 0.01 vs.
H/R group.
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suspension to react with the nitro blue tetrazolium. The
intensity of absorbance of the mixture was also determined
by spectrophotometer at 550 nm. The SOD activity was
expressed as U/mg protein.Figure 2. Effects of propofol preconditioning on GES-1 cell apopt
apoptosis cells; each value represents the mean  standard deviat
Scale bar represents 50 mm. (C) Flow cytometric assay was used to
H/R, F and P groups, respectively.Statistical data analysis
Data were shown as mean  standard deviation (SD). One-
way analysis of variance was performed to analyze the data
using SPSS 13.0. Differences between the experimentalosis induced by H/R. (A, B) Hoechst 33258 was used to stain the
ion (n Z 3). **p < 0.01 vs. N group. ##p < 0.01 vs. H/R group.
detect the percentage of apoptotic and necrotic cells in the N,
Table 1 The percentage of apoptotic cells, apoptotic plus
necrotic cells, and necrotic GES-1 cells detected by flow
cytometric assay in normal, hypoxia/reoxygenation, fat
emulsion preconditioning and propofol preconditioning
groups respectively (n Z 3).
Apoptosis Apoptosis þ necrosis Necrosis
N 12.30%  0.82% 8.53%  0.74% 1.17%  0.26%
H/R 34.52%  0.65%** 23.34%  0.76%** 7.30%  0.38%**
F 33.76%  0.73% 23.01%  0.39% 7.19%  0.64%
P 25.62%  0.53%## 12.73%  0.76%## 4.64%  0.57%##
**p < 0.01 vs. N group. ##p < 0.01 vs. H/R group.
FZ fat emulsion (50 mmol/L) preconditioning under hypoxia 1.5
hours/reoxygenation 2 hours; H/R Z hypoxia 1.5 hours/reox-
ygenation 2 hours; N Z normoxic culture for 3.5 hours;
P Z propofol (50 mmol/L) preconditioning under hypoxia 1.5
hours/reoxygenation 2 hours.
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Keuls test. A p value of <0.05 was considered as statisti-
cally significant.Results
The effect of propofol on GES-1 cell viability under
H/R conditions
Cell viability was detected by MTT. We observed that pro-
pofol (5, 10, 50, and 100 mmol/L) promoted GES-1 cellFigure 3. Effects of propofol preconditioning on the protein exp
represents the mean  standard deviation (n Z 6). *p < 0.05. **pviability in conditions of hypoxia 3 hours/reoxygenation 12
hours (p < 0.05) and that propofol 50 mmol/L was the
optimal protective dose (p < 0.01) (Fig. 1A). We therefore
chose this concentration of propofol for analysis in the
subsequent experiments. The effects of propofol on cell
viability at different time points indicated that propofol
could promote cell viability under hypoxia (1.5, 3, and 6
hours)/reoxygenation 12 hours (p < 0.05), and the most
obviously protective effect was under hypoxia 1.5 hours/
reoxygenation 12 hours (p < 0.05) (Fig. 1B). Propofol was
able to promote cell viability under hypoxia 1.5 hours/
reoxygenation 2, 4, 6, 8, and 12 hours (p < 0.05), and the
most striking protective effect was under hypoxia 1.5
hours/reoxygenation 2 hours (p < 0.05) (Fig. 1C). Fat
emulsion did not affect cell viability under H/R conditions
(Fig. 1D). These data indicated that propofol 50 mmol/L
attenuated GES-1 cell injury induced by hypoxia 1.5 hours/
reoxygenation 2 hours, therefore, this model was used in
the following experiments.
Effects of propofol on apoptosis and necrosis in
GES-1 cells under H/R conditions
Next, the apoptotic GES-1 cells were assayed by Hoechst
33258 staining. The number of apoptotic cells with kar-
yopyknosis significantly increased in the H/R group
(p < 0.01). Pretreatment with propofol inhibited GES-1 cell
apoptosis and the apoptotic cells in the P group were
decreased compared to the H/R group (p < 0.01) (Fig. 2A
and B).
Moreover, flow cytometry was used to detect the
percentage of apoptotic cells, apoptotic cells plus necroticression of (A) Bax, (B) Bcl-2 and(C) Bax/Bcl-2 ratio. Each value
< 0.01 vs. N group. #p < 0.05 vs. H/R group.
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respectively (Fig. 2C and Table 1). Compared to the N
group, the number of apoptotic cells, apoptotic cells plus
necrotic cells and necrotic cells were all increased in the H/
R and F groups (p < 0.01). In the P group, there were fewer
apoptotic cells, apoptotic cells plus necrotic cells and
necrotic cells in comparison with the H/R group (p < 0.01).
In order to further understand the effect of propofol on
cell apoptosis at a molecular level, Bcl-2 and Bax protein
expressions were measured (Fig. 3). The results indicated
that protein levels of Bax (Fig. 3A) increased (p < 0.01) and
Bcl-2 (Fig. 3B) levels decreased significantly in the H/R
group compared to the N group (p < 0.01). Propofol
pretreatment inhibited the increased expression of Bax,
enhanced Bcl-2 expression, and depressed the ratio of Bax/
Bcl-2 (Fig. 3C) compared with the H/R group (p < 0.01).
The role of TLR4 in H/R injury and the effects of
propofol on TLR4 signal-related protein expression
of GES-1 cells under H/R conditions
To determine whether TLR4 was involved in the protective
effect of propofol on GES-1 cell H/R injury, an inhibitor of
TLR4, EGCG, was used to detect cell viability. Results
indicated that, compared to the H/R group, EGCG pre-
conditioning enhanced cell viability (p < 0.01). InFigure 4. The role of TLR4 in the H/R injury and effect of propof
(A) Cell viability was detected in H/R, E, P and Eþ P groups under hyp
mean standard deviation (nZ 6). a p< 0.01, ##p< 0.01 vs. H/R gro
expression of TLR4 was determined by Western blotting analyses.
**p<0.01 vs.Ngroup. ##p<0.01 vs.H/Rgroup. (C)ThemRNAexpress
chain reaction. Each value represents the mean  standard deviatiocomparison with the P and E groups, EGCG combined with
propofol preconditioning further improved cell viability
(p < 0.05) (Fig. 4A). Moreover, the protein (Fig. 4B) and
mRNA expression (Fig. 4C) of TLR4 were assayed by Western
blotting and quantitative real-time polymerase chain
reaction, respectively. The results indicated that,
compared with the N group, the protein and mRNA
expression of TLR4 were significantly increased in the H/R
and F groups (p < 0.01), while propofol down-regulated the
increased expression of the protein and mRNA (p < 0.01).
In order to further understand the effect of propofol on
downstream molecules in the TLR4 signal pathway, Western
blotting was used. The results indicated that the protein
expressions of MyD88, p-IkB-a and NF-kB p65 in the nucleus
were significantly increased in the H/R and F groups in
comparison with the N group (p < 0.05). Meanwhile, pro-
pofol preconditioning decreased the expressions of these
proteins; IkB-a demonstrated an inverse profile compared
to both p-IkB-a and NF-kB p65 in the nucleus, with propofol
increasing IkB-a levels (p < 0.01) (Fig. 5).
Effects of propofol on the MDA contents and SOD
activities of GES-1 cells under H/R conditions
Finally, to determine whether propofol attenuated GES-1
cell injury following H/R related to the production ofol preconditioning on the protein and mRNA expression of TLR4.
oxia 1.5 hours/reoxygenation 2 hours. Each value represents the
up. b p< 0.05 vs. E group. c p< 0.05 vs. P group. (B) The protein
Each value represents the mean  standard deviation (n Z 6).
ion ofTLR4wasdeterminedbyquantitative real-timepolymerase
n (nZ 3). **p < 0.01 vs. N group. ##p < 0.01 vs. H/R group.
Figure 5. Effects of propofol preconditioning on the protein expression of MyD88, IkB-a, p- IkB-a and NF-kB p65 in the nucleus of
GES-1 cells under H/R conditions. The expression of b-actin was measured as an internal standard. (A) MyD88; (B) IkB-a; (C) p-IkB-a;
and (D) NF-kB p65 in the nucleus. Each value represents the mean  standard deviation (nZ 6). *p < 0.05. ** p < 0.01 vs. N group.
#p < 0.05. ##p < 0.01 vs. H/R group.
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SOD activities of GES-1 cells. MDA contents were signifi-
cantly elevated in the H/R and F groups in comparison with
the N group (p < 0.01). Pretreatment with propofol signif-
icantly decreased the MDA contents (p < 0.01) (Fig. 6A) and
increased the enzymatic activities of SOD of in comparison
with the H/R group (p < 0.05) (Fig. 6B).
Discussion
In the present study, H/R injury in GES-1 cells led to
a reduction in cell viability, an increase cell apoptosis, an
increase in MDA content and a decrease in SOD activity. H/R
injury in GES-1 cells not only increased TLR4 expression but
also increased MyD88, p-IkB-a and nucleus NF-kB p65
expression, while it decreased IkB-a expression. Further-
more, propofol preconditioning enhanced cell viability,
decreased cell apoptosis, inhibited TLR4 signal pathway
activation, reduced MDA contents, and made SOD activities
recovered to normal levels gradually.
One important finding in the study was that the TLR4
signal could be activated in GES-1 cells under H/R injury
through a MyD88-dependent pathway. et al. [20] reported
that TLR4 played a critical role in heart I/RI. MyD88, which
is one of the TLR4 adaptor molecules, has been reported to
be expressed throughout the gut [21], and was sequentially
recruited when a TLR4-mediated signal occurred [22]. Li
et al. [23] reported that TLR4 mediated the proximal tubuleepithelial cell H/R injury mainly via a MyD88 dependent-
pathway, underlining the important role of MyD88-
dependent mechanisms in renal tubular I/RI. However,
whether TLR4 is involved in H/R injury in GES-1 cells is
unclear. In our study, the expression of TLR4 and MyD88 was
increased under H/R conditions. EGCG, an inhibitor of
TLR4, enhanced cell viability under H/R conditions. These
data suggest that the TLR4 signal may be involved in GES-1
cell injury induced by H/R via the MyD88-dependent
pathway.
In various cell types, NF-kB exists constitutively in
a latent, inactive form in the cell cytosol. A lot of stress
could induce the phosphorylation of IkB-a, followed by the
ubiquitination and degradation of IkB-a [24] and induce
NF-kB transfer into the nucleus [25]. TLR4 activation is
a premise for TLR4-mediated NF-kB activation via the
MyD88-dependent pathway. A study has reported that
NF-kB plays an important role in the gastric I/RI of the
Sprague Dawley rat [26]. Our study indicated that TLR4
downstream molecules were involved in GES-1 cell H/R
injury, with an increase of the protein expression of NF-kB
p65 and p-IkB-a in the nucleus and a decrease of IkB-a
expression, confirming our supposition that TLR4 signaling
may be involved in H/R injury in GES-1 cells via the MyD88-
dependent pathway.
Is there an interaction between oxidative stress and the
TLR4 signal? It has been well established that the genera-
tion of reactive oxygen species by Kupffer cells directly
Figure 6. Effects of propofol preconditioning on GES-1 cells’ (A) malondialdehyde (MDA) contents and (B) superoxide dismutase
(SOD) under H/R conditions. Each value represents the mean  standard deviation (n Z 6). *p < 0.05. **p < 0.01 vs. N group.
#p < 0.05. ##p < 0.01 vs. H/R group.
296 J.-L. Zhang et al.increases the activity of NF-kB and then facilitates nuclear
translocation [27]. Furthermore, a pattern recognition
receptor located on Kupffer cells is required to activate
transcriptional elements, including NF-kB. The activated
NF-kB then induces the release of kinds of proinflammatory
cytokines, and these cytokines induce the feedback acti-
vation of TLR4 resulting in the infiltration of neutrophils
and injury [28]. The oxidationereduction system may
therefore be involved in the activation of the TLR4 signal as
follows: reactive oxygen species promoted the activation of
the TLR4 signal, while SOD inhibited the activation of the
TLR4 signal through NF-kB. The data in our study also
indicate that MDA, as a sign of lipid peroxidation, was
increased under H/R conditions, while SOD activity
decreased.
Although many studies have focused on H/R injury in
cells, an agent that could effectively protect against the
cell injury remains unclear. According to a review on the
protective effects of propofol on organ I/RI, the key
factors for the effects include the preservation of ATP
levels and remission the oxidative stress-induced inflam-
matory injury [29]. It has been documented that propofol
has anti-inflammatory effects against lipopolysaccharide
(LPS)-induced alveolar type II epithelial cell injury by
down-regulating the protein expression of TLR4 [30].
Moreover, propofol may inhibit the phosphorylation and
degradation of IkB-a, resulting in NF-kB inactivation in
hepatocytes [31]. Placing our work within the context of
these findings, we found that propofol 50 mmol/L signifi-
cantly promoted GES-1 cell viability under hypoxia 1.5
hours/reoxygenation 2 hours. While studies have reported
that blood concentration of propofol is 5–30 mmol/L [32] in
clinics. Inappropriate treatment with propofol can lead to
propofol infusion syndrome [33,34], so the effect of pro-
pofol on gastric I/RI in vivo is of particular interest.
Pretreatment with propofol could decrease the
percentage of apoptotic cells in the study. Bcl-2, a kind of
anti-apoptotic protein, can inhibit the apoptotic process via
direct interaction with proapoptotic proteins (Bax/Bak)
[35]. The results in our study showed the increased ratio ofBax/Bcl-2 expression under propofol preconditioning, sug-
gesting that preconditioning with propofol might inhibit cell
apoptosis as well.
We also observed that the protective and antiapoptotic
effects of propofol correlated with decreased protein levels
of key components in the TLR4 pathway, including TLR4,
MyD88, and NF-kB. These results support the idea that
propofol inhibits H/R-induced injury in GES-1 cells by sup-
pressing the TLR4 signal.
Because of the antioxidative effect of propofol, pre-
conditioning with this drug decreased the MDA content and
enhanced SOD activity in GES-1 cells under H/R injury. The
relationship between the TLR4 signal and SOD activity,
elaborated above, means that all of the results in our study
indicate that propofol may exert a protective effect against
H/R injury in GES-1 cells by directly and indirectly sup-
pressing TLR4 signal.
Fat emulsion, a kind of solvent of propofol, was used
clinically as a kind of nutritional support. Dogan et al. [36]
reported that propofol exerted a protective effect against
renal I/RI that was irrelevant to fat emulsion. Our study
indicates that fat emulsion does not affect the GES-1 cell
injury under H/R, which further confirms our hypothesis
that propofol may exert a protective effect against H/R
injury in GES-1 cell by suppressing the TLR4 signal.Conclusion
Our study confirmed that propofol exerted a protective
effect against GES-1 cell injury induced by H/R in vitro,
accompanied by decreased GES-1 cell apoptosis and
increased cell viability. Consequently, the administration of
propofol may clinically benefit patients subjected to gastric
I/RI. Moreover, these data also indicate that the TLR4 signal
pathway may be a potential therapeutic target in gastric
mucosal I/RI in vivo. However, this study is restricted to
human gastric epithelial cells in vitro under H/R and
further studies are needed to elaborate the feasibility and
efficacy of propofol in a clinical setting.
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